Benjamin Jackson CFA
Stock Analyst at Jefferies
(3.32)
# 2,558
Out of 5,005 analysts
77
Total ratings
60%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by Benjamin Jackson CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 205.00 | CHF 162.00 | +26.54% | 34 | Sep 21, 2026 | |
| GMAB Genmab | Reiterated: Buy | n/a | $35.36 | - | 2 | Aug 7, 2026 | |
| EPA: IPN Ipsen S.A. | Downgraded: Sell | €117.00 → €135.00 | €143.50 | -5.92% | 3 | Aug 3, 2026 | |
| SWX: CMHC Cosmo N.V. | Reiterated: Buy | CHF 140.00 → CHF 110.00 | CHF 54.00 | +103.70% | 3 | Jul 28, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 110.00 | CHF 121.40 | -9.39% | 5 | Feb 4, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €100.00 | €72.00 | +38.89% | 9 | Dec 29, 2025 | |
| SWX: ROP Roche Holding AG | Downgraded: Sell | CHF 270.00 → CHF 230.00 | CHF 355.40 | -35.28% | 6 | Oct 27, 2025 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,450p | 1,860p | n/a | 2 | Jul 30, 2025 | |
| LON: AZN AstraZeneca PLC | Reiterated: Hold | 10,900p | 12,492p | n/a | 2 | Jul 29, 2025 | |
| ETR: EVT Evotec SE | Reiterated: Hold | €6.80 | €2.86 | n/a | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.8 | $1.59 | n/a | 1 | Oct 7, 2024 |
Galderma Group AG
Sep 21, 2026
Reiterated: Buy
Price Target: CHF 205.00
Current: CHF 162.00
Upside: +26.54%
Genmab
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.36
Upside: -
Ipsen S.A.
Aug 3, 2026
Downgraded: Sell
Price Target: €117.00 → €135.00
Current: €143.50
Upside: -5.92%
Cosmo N.V.
Jul 28, 2026
Reiterated: Buy
Price Target: CHF 140.00 → CHF 110.00
Current: CHF 54.00
Upside: +103.70%
Novartis AG
Feb 4, 2026
Reiterated: Hold
Price Target: CHF 110.00
Current: CHF 121.40
Upside: -9.39%
Sanofi
Dec 29, 2025
Reiterated: Buy
Price Target: €100.00
Current: €72.00
Upside: +38.89%
Roche Holding AG
Oct 27, 2025
Downgraded: Sell
Price Target: CHF 270.00 → CHF 230.00
Current: CHF 355.40
Upside: -35.28%
GSK plc
Jul 30, 2025
Reiterated: Hold
Price Target: 1,450p
Current: 1,860p
Upside: n/a
AstraZeneca PLC
Jul 29, 2025
Reiterated: Hold
Price Target: 10,900p
Current: 12,492p
Upside: n/a
Evotec SE
Nov 13, 2024
Reiterated: Hold
Price Target: €6.80
Current: €2.86
Upside: n/a
Oct 7, 2024
Downgraded: Hold
Price Target: $3.8
Current: $1.59
Upside: n/a